A SNARE protective pool antagonizes APOL1 renal toxicity in Drosophila nephrocytes

被引:3
|
作者
Lee, Jin-Gu [1 ,2 ]
Fu, Yulong [1 ,4 ]
Zhu, Jun-yi [1 ,2 ]
Wen, Pei [1 ,2 ]
van de Leemput, Joyce [1 ,2 ]
Ray, Patricio E. [3 ]
Han, Zhe [1 ,2 ]
机构
[1] Univ Maryland, Ctr Precis Dis Modeling, Sch Med UMSOM, Dept Med, 670 West Baltimore St,4052 HSFIII, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
[3] Univ Virginia, Child Hlth Res Ctr, Sch Med, Dept Pediat, 409 Lane Rd, Charlottesville, VA 22908 USA
[4] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35249 USA
关键词
SNARE proteins; SNARE protective pool; APOL1; Renal toxicity; Nephrocytes; Serum resistance-associated (SRA) protein; RISK VARIANTS; KIDNEY-DISEASE; AFRICAN-AMERICANS; GENE; CELL; CYTOTOXICITY; PROTEIN; INJURY;
D O I
10.1186/s13578-023-01147-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background People of Sub-Saharan African ancestry are at higher risk of developing chronic kidney disease (CKD), attributed to the Apolipoprotein L1 (APOL1) gene risk alleles (RA) G1 and G2. The underlying mechanisms by which the APOL1-RA precipitate CKD remain elusive, hindering the development of potential treatments.Results Using a Drosophila genetic modifier screen, we found that SNARE proteins (Syx7, Ykt6, and Syb) play an important role in preventing APOL1 cytotoxicity. Reducing the expression of these SNARE proteins significantly increased APOL1 cytotoxicity in fly nephrocytes, the equivalent of mammalian podocytes, whereas overexpression of Syx7, Ykt6, or Syb attenuated their toxicity in nephrocytes. These SNARE proteins bound to APOL1-G0 with higher affinity than APOL1-G1/G2, and attenuated APOL1-G0 cytotoxicity to a greater extent than either APOL1-RA.Conclusions Using a Drosophila screen, we identified SNARE proteins (Syx7, Ykt6, and Syb) as antagonists of APOL1-induced cytotoxicity by directly binding APOL1. These data uncovered a new potential protective role for certain SNARE proteins in the pathogenesis of APOL1-CKD and provide novel therapeutic targets for APOL1-associated nephropathies.
引用
收藏
页数:14
相关论文
共 39 条
  • [11] APOL1 high-risk genotypes and renal transplantation
    Shah, Sapna
    Shapiro, Ron
    Murphy, Barbara
    Menon, Madhav C.
    CLINICAL TRANSPLANTATION, 2019, 33 (06)
  • [12] APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial
    Freedman, Barry I.
    Rocco, Michael V.
    Bates, Jeffrey T.
    Chonchol, Michel
    Hawfield, Amret T.
    Lash, James P.
    Papademetriou, Vasilios
    Sedor, John R.
    Servilla, Karen
    Kimmel, Paul L.
    Wall, Barry M.
    Pajewski, Nicholas M.
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (04): : 713 - 720
  • [13] APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress
    Wakashin, Hidefumi
    Heymann, Jurgen
    Roshanravan, Hila
    Daneshpajouhnejad, Parnaz
    Rosenberg, Avi
    Shin, Myung Kyun
    Hoek, Maarten
    Kopp, Jeffrey B.
    BMC NEPHROLOGY, 2020, 21 (01)
  • [14] Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells
    Cheng, Dongmei
    Weckerle, Allison
    Yu, Yi
    Ma, Lijun
    Zhu, Xuewei
    Murea, Mariana
    Freedman, Barry I.
    Parks, John S.
    Shelness, Gregory S.
    JOURNAL OF LIPID RESEARCH, 2015, 56 (08) : 1583 - 1593
  • [15] APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8
    Madhavan, Sethu M.
    O'Toole, John F.
    Konieczkowski, Martha
    Barisoni, Laura
    Thomas, David B.
    Ganesan, Santhi
    Bruggeman, Leslie A.
    Buck, Matthias
    Sedor, John R.
    JCI INSIGHT, 2017, 2 (14):
  • [16] APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
    Cooper, Anneli
    Ilboudo, Hamidou
    Alibu, V. Pius
    Ravel, Sophie
    Enyaru, John
    Weir, William
    Noyes, Harry
    Capewell, Paul
    Camara, Mamadou
    Milet, Jacqueline
    Jamonneau, Vincent
    Camara, Oumou
    Matovu, Enock
    Bucheton, Bruno
    MacLeod, Annette
    ELIFE, 2017, 6
  • [17] Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort
    Kozlitina, Julia
    Zhou, Haihong
    Brown, Patricia N.
    Rohm, Rory J.
    Pan, Yi
    Ayanoglu, Gulesi
    Du, Xiaoyan
    Rimmer, Eric
    Reilly, Dermot F.
    Roddy, Thomas P.
    Cully, Doris F.
    Vogt, Thomas F.
    Blom, Daniel
    Hoek, Maarten
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (10): : 3204 - 3219
  • [18] Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease
    Anyaegbu, Elizabeth I.
    Shaw, Andrey S.
    Hruska, Keith A.
    Jain, Sanjay
    PEDIATRIC NEPHROLOGY, 2015, 30 (06) : 983 - 989
  • [19] Evolution of Renal-Disease Factor APOL1 Results in Cis and Trans Orientations at the Endoplasmic Reticulum That Both Show Cytotoxic Effects
    Mueller, Daria
    Schmitz, Juergen
    Fischer, Katharina
    Granado, Daniel
    Groh, Ann-Christin
    Krausel, Vanessa
    Luettgenau, Simona Mareike
    Amelung, Till Maximilian
    Pavenstaedt, Hermann
    Weide, Thomas
    MOLECULAR BIOLOGY AND EVOLUTION, 2021, 38 (11) : 4962 - 4976
  • [20] APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy
    Kopp, Jeffrey B.
    Heymann, Jurgen
    Winkler, Cheryl A.
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 514 - 519